Mouse Study Hints during New Path for Diabetes Treatment

<p>THURSDAY, Apr 12 (HealthDay News) A intensity new treatment
for type 2 diabetes targets a hormone glucagon instead of insulin,
according to a new investigate in mice.
Although a investigate hasnt nonetheless progressed past animal models of the
disease, initial formula advise that a novel therapy can reduce blood
sugar, diminution insulin resistance, reduce cholesterol and assistance keep fatty
deposits from settling in a liver.
Whats more, a researchers didnt see any adverse effects from the
treatment.
A new aim for a inauspicious effects of glucagon on diabetes has been
identified, and with diagnosis we got absolved of all a bad stuff, yet didnt
cause side effects, pronounced a studys lead author, Dr. Ira Tabas, a
distinguished highbrow of medicine during Columbia University Medical Center,
in New York City.
Results of a investigate are published in a Apr 12 online book of
Cell Metabolism.
Glucagon is a hormone whose categorical purpose is to strengthen a physique and b...